Search

Your search keyword '"Kostner, Karam"' showing total 473 results

Search Constraints

Start Over You searched for: Author "Kostner, Karam" Remove constraint Author: "Kostner, Karam"
473 results on '"Kostner, Karam"'

Search Results

2. Unresolved Questions

7. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

8. Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations

11. Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective

12. Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia

13. Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry

14. Australian and New Zealand Living Guideline cholesterol‐lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence‐practice gap.

15. Prognostic utility of serum NT-proBNP (fragments 1-76aa and 13-71aa) and galectin-3 in predicting death and re-hospitalisation due to cardiovascular events in patients with heart failure

19. Omega‐3 fatty acids and cardiovascular prevention: is the jury still out?

22. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

35. Corrigendum to Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: An Australian perspective [American Journal of Preventive Cardiology 6 (2021) 100151]

37. Asian Pacific Society of Cardiology Consensus Recommendations on Dyslipidaemia

38. Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG

39. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

40. Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective

43. Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia

44. Farnesoid X receptor represses hepatic human APOA gene expression

46. The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)

Catalog

Books, media, physical & digital resources